| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Algorithm for neuropathic pain treatment: an evidence based proposal.
|
Pain
|
2005
|
3.92
|
|
2
|
Statins and risk of polyneuropathy: a case-control study.
|
Neurology
|
2002
|
1.97
|
|
3
|
Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial.
|
Eur J Neurol
|
2009
|
1.73
|
|
4
|
The clinical picture of neuropathic pain.
|
Eur J Pharmacol
|
2001
|
1.53
|
|
5
|
Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management.
|
Diabetes Metab Res Rev
|
2011
|
1.50
|
|
6
|
[Syndrome of headache, transitory neurological deficits and lymphocytosis in the cerebrospinal fluid].
|
Ugeskr Laeger
|
2000
|
1.38
|
|
7
|
Pain and dysesthesia in patients with spinal cord injury: A postal survey.
|
Spinal Cord
|
2001
|
1.30
|
|
8
|
The hypoalgesic effect of tramadol in relation to CYP2D6.
|
Clin Pharmacol Ther
|
1996
|
1.26
|
|
9
|
Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy.
|
Eur J Neurol
|
2013
|
1.17
|
|
10
|
Lipid-lowering drugs and risk of myopathy: a population-based follow-up study.
|
Epidemiology
|
2001
|
1.15
|
|
11
|
The postmastectomy pain syndrome: an epidemiological study on the prevalence of chronic pain after surgery for breast cancer.
|
Br J Cancer
|
2008
|
1.10
|
|
12
|
Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects.
|
Eur J Clin Pharmacol
|
1996
|
1.08
|
|
13
|
Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine.
|
Eur J Clin Pharmacol
|
1993
|
1.04
|
|
14
|
Subcutaneous immunoglobulin preserves muscle strength in chronic inflammatory demyelinating polyneuropathy.
|
Eur J Neurol
|
2014
|
1.02
|
|
15
|
Is overuse of sumatriptan a problem? A population-based study.
|
Eur J Clin Pharmacol
|
1996
|
0.96
|
|
16
|
The analgesic effect of codeine as compared to imipramine in different human experimental pain models.
|
Pain
|
2001
|
0.96
|
|
17
|
Evaluation of patients with symptoms suggestive of chronic polyneuropathy.
|
J Clin Neuromuscul Dis
|
2001
|
0.94
|
|
18
|
Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia.
|
Acta Anaesthesiol Scand
|
2009
|
0.92
|
|
19
|
The hypoalgesic effect of imipramine in different human experimental pain models.
|
Pain
|
1995
|
0.91
|
|
20
|
Inappropriate use of sumatriptan: population based register and interview study.
|
BMJ
|
1998
|
0.90
|
|
21
|
Interobserver variation in the evaluation of neurological signs: observer dependent factors.
|
Acta Neurol Scand
|
1994
|
0.89
|
|
22
|
Effect of levetiracetam on the postmastectomy pain syndrome.
|
Eur J Neurol
|
2008
|
0.89
|
|
23
|
Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?
|
Eur J Clin Pharmacol
|
2001
|
0.89
|
|
24
|
Paroxetine, a cytochrome P450 2D6 inhibitor, diminishes the stereoselective O-demethylation and reduces the hypoalgesic effect of tramadol.
|
Clin Pharmacol Ther
|
2005
|
0.88
|
|
25
|
Citalopram: interaction studies with levomepromazine, imipramine, and lithium.
|
Ther Drug Monit
|
1993
|
0.88
|
|
26
|
Effect of short-term hyperglycemia per se on nociceptive and non-nociceptive thresholds.
|
Pain
|
1994
|
0.87
|
|
27
|
Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies.
|
Eur J Neurol
|
2014
|
0.87
|
|
28
|
Levetiracetam in spinal cord injury pain: a randomized controlled trial.
|
Spinal Cord
|
2009
|
0.86
|
|
29
|
Sensory function and pain in a population of patients treated for breast cancer.
|
Acta Anaesthesiol Scand
|
2009
|
0.84
|
|
30
|
Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker.
|
Eur J Clin Pharmacol
|
2009
|
0.84
|
|
31
|
Statins and peripheral neuropathy.
|
Eur J Clin Pharmacol
|
1999
|
0.84
|
|
32
|
Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans.
|
Clin Pharmacol Ther
|
2001
|
0.84
|
|
33
|
Inter-observer variation in the evaluation of neurological signs: patient-related factors.
|
J Neurol
|
1994
|
0.82
|
|
34
|
Escitalopram is a weak inhibitor of the CYP2D6-catalyzed O-demethylation of (+)-tramadol but does not reduce the hypoalgesic effect in experimental pain.
|
Clin Pharmacol Ther
|
2009
|
0.80
|
|
35
|
Therapeutic outcome in neuropathic pain: relationship to evidence of nervous system lesion.
|
Eur J Neurol
|
2004
|
0.80
|
|
36
|
Role of genetic polymorphism in psychopharmacology--an update.
|
Psychopharmacol Ser
|
1993
|
0.80
|
|
37
|
A randomized, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis.
|
Eur J Pain
|
2011
|
0.76
|
|
38
|
Codeine in post-operative pain. Study of the influence of sparteine phenotype and serum concentrations of morphine and morphine-6-glucuronide.
|
Eur J Clin Pharmacol
|
1998
|
0.76
|
|
39
|
Sodium valproate in painful diabetic polyneuropathy.
|
Acta Neurol Scand
|
2003
|
0.75
|
|
40
|
[Chronic neuropathic pain after surgery].
|
Ugeskr Laeger
|
1999
|
0.75
|
|
41
|
Tricyclic antidepressants in "central pain".
|
Acta Neurol Scand
|
1991
|
0.75
|
|
42
|
[Combination preparations of codeine and paracetamol].
|
Ugeskr Laeger
|
1998
|
0.75
|
|
43
|
[Clinical chemical parameters for metabolic control of patients with diabetes mellitus].
|
Nord Med
|
1989
|
0.75
|
|
44
|
[Interobserver variation in the evaluation of neurobiological findings: observer-dependent and patient-dependent variables].
|
Ugeskr Laeger
|
1995
|
0.75
|
|
45
|
Different short-term effect of protein and carbohydrate intake on TSH, growth hormone (GH), insulin, C-peptide, and glucagon in humans.
|
Scand J Clin Lab Invest
|
1990
|
0.75
|